Lv41
438 积分 2024-08-20 加入
Ponsegromab for the Treatment of Cancer Cachexia
2小时前
待确认
Engineering IL-2 for immunotherapy of autoimmunity and cancer
28天前
已完结
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
1个月前
已完结
Correction:EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
1个月前
已完结
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial
1个月前
已完结
Interleukin-2–based therapies in cancer
1个月前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
1个月前
已完结
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
1个月前
已完结
Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy
1个月前
已完结
Interleukin-2–based therapies in cancer
1个月前
已完结
皖公网安备34019202002308
